LRRK2 and Parkinson disease: None of the remaining regions previously shown to be associated with PD or AD by GWAS showed sign of strong association with DLB (Supplementary Material, Figures); including LRRK2, which is known to have both disease-causing mutations as well as risk-conferring variants for PD.